26.10.2021 • News

Biesterfeld Takes Majority of GME Chemicals

Hamburg-based German distributor Biesterfeld has closed its acquisition of a majority stake in Singapore-based GME Chemicals. The distributor did not quantify the size of the stake but said it plans to purchase the remaining shares over a five-year period. The parties have agreed not to disclose details of the transaction, which will leave GME’s management team and employees in place.

With the deal, Biesterfeld said it is laying the foundation for a “targeted and long-term expansion” of its market position in one of the world's fastest-growing regions for its core business. Established in 1999, GME is regarded as a leading distributor of specialty chemicals and polymers in Southeast Asia.

In particular, the Singapore- based company, which employs 60 people, is active in the markets for performance and industrial chemicals, food, pharmaceuticals, elastomers and specialty polymers, with operating subsidiaries in Malaysia, Indonesia, Vietnam, Thailand and China.

Integrating the new activities with its own, Biesterfeld CEO Thomas Arnold said the distributor is strengthening and expanding its competencies. Together with GME, it will drive forward its strategy of continuous expansion in Asia to jointly develop further markets and segments for its technically complex and consulting-intensive products and services portfolio.

Philip Chew, managing director and shareholder of GME Chemicals, added that by combining the Singapore company’s knowhow with that of Biesterfeld, “we can jointly and significantly expand the solution portfolio for customers in Asia and accelerate the growth of our suppliers in our markets.”

Author: Dede Williams, Freelance Journalist

 

Hamburg-based German distributor Biesterfeld has closed its acquisition of a...
Hamburg-based German distributor Biesterfeld has closed its acquisition of a majority stake in Singapore-based GME Chemicals. The distributor did not quantify the size of the stake but said it plans to purchase the remaining shares over a five-year period. (c) Cytonn Photography

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.